|Articles|April 2, 2013
Opportunities and Challenges in Developing Stem Cell Therapies
A conversation with Armand Keating, the Epstein Chair in Cell Therapy and Transplantation at the University of Toronto prior to his presentation at Bio 2013
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
2
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
3
Biocapacitance as a PAT Tool: Real-Time Biomass Monitoring for Upstream Bioprocessing
4
How Engineered Exosomes Can Impact Targeted Therapies
5
